We are live on ! Find out more

966 hedge funds and large institutions have $19.2B invested in Labcorp in 2022 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 352 increasing their positions, 373 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more call options, than puts

Call options by funds: $96.5M | Put options by funds: $52.3M

10% more funds holding in top 10

Funds holding in top 10: 2022 (+2)

0.75% more ownership

Funds ownership: 102.59%103.34% (+0.75%)

6% less repeat investments, than reductions

Existing positions increased: 352 | Existing positions reduced: 373

6% less funds holding

Funds holding: 1,033966 (-67)

11% less capital invested

Capital invested by funds: $21.6B → $19.2B (-$2.47B)

47% less first-time investments, than exits

New positions opened: 57 | Existing positions closed: 107

Holders
966
Holders Change
-67
Holders Change %
-6.49%
% of All Funds
16.27%
Holding in Top 10
22
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+10%
% of All Funds
0.37%
New
57
Increased
352
Reduced
373
Closed
107
Calls
$96.5M
Puts
$52.3M
Net Calls
+$44.2M
Net Calls Change
-$82.5M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$2.62B +$399M +1,871,130 +17%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.54B -$8.98M -42,134 -0.3%
State Street
3
State Street
Massachusetts
$994M -$14M -65,812 -1%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$671M +$31.9M +149,597 +5%
JP Morgan Chase
5
JP Morgan Chase
New York
$446M +$157M +737,330 +50%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$442M +$5.57M +26,145 +1%
Bank of America
7
Bank of America
North Carolina
$439M +$23.6M +110,557 +5%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$367M +$1.7M +7,960 +0.4%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$320M +$11.8M +55,292 +4%
UBS AM
10
UBS AM
Illinois
$283M +$30.8M +144,475 +11%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$282M +$7.63M +35,795 +3%
Northern Trust
12
Northern Trust
Illinois
$267M -$1.08M -5,080 -0.4%
Morgan Stanley
13
Morgan Stanley
New York
$243M +$75.7M +355,277 +42%
MIM
14
Meridiem Investment Management
United Kingdom
$222M +$34.6M +162,109 +17%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$217M -$234M -1,097,269 -50%
Thrivent Financial for Lutherans
16
Thrivent Financial for Lutherans
Minnesota
$210M +$217M +1,016,688 +3,972%
Norges Bank
17
Norges Bank
Norway
$207M -$10.8M -50,598 -5%
JP
18
Jana Partners
New York
$199M +$98.2M +460,630 +88%
First Trust Advisors
19
First Trust Advisors
Illinois
$196M +$168M +788,653 +427%
Legal & General Group
20
Legal & General Group
United Kingdom
$183M +$14.2M +66,727 +8%
AI
21
Ariel Investments
Illinois
$177M +$10.4M +48,697 +6%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$162M -$16.5M -77,377 -9%
Invesco
23
Invesco
Georgia
$150M +$4.96M +23,284 +3%
AllianceBernstein
24
AllianceBernstein
Tennessee
$137M +$6.74M +31,640 +5%
CB
25
Cooke & Bieler
Pennsylvania
$130M +$47.8M +224,230 +53%

LH Hedge Fund Activity: Q2 2022 in Review

966 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2022, worth a combined $19.2B — down 11% from $21.6B a quarter earlier.

Sellers outnumbered buyers: 107 funds closed out of LH and 57 opened new positions — a net loss of 50 holders — while 373 trimmed existing stakes and 352 added.

The largest buyer was BlackRock, adding an estimated $399M. The largest seller was T. Rowe Price Associates, cutting an estimated $234M.

  • 966 institutional investors held Labcorp (LH) as of Q2 2022, down from 1,033 in Q1 2022.
  • Funds reported $19.2B of Labcorp stock for Q2 2022, down 11% quarter-over-quarter.
  • 57 funds opened new Labcorp positions in Q2 2022 and 107 closed out, a net change of -50 holders.
  • The largest Labcorp buyer in Q2 2022 was BlackRock, an estimated $399M added.
  • The largest Labcorp seller in Q2 2022 was T. Rowe Price Associates, an estimated $234M sold.

Based on aggregated 13F filings for Q2 2022.